This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/DOC: Difference between revisions
Jump to navigation
Jump to search
>Viscid Added Class Membership |
>Josikins No edit summary |
||
| Line 53: | Line 53: | ||
|InsufflatedROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. | |InsufflatedROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. | ||
|InsufflatedROA_Bioavailability= | |InsufflatedROA_Bioavailability= | ||
|InsufflatedROA_Threshold=0. | |InsufflatedROA_Threshold=0.5 mg | ||
|InsufflatedROA_Light=0.5 - | |InsufflatedROA_Light=0.5 - 1 mg | ||
|InsufflatedROA_Common=1 - | |InsufflatedROA_Common=1 - 2 mg | ||
|InsufflatedROA_Strong=2.5 - 3. | |InsufflatedROA_Strong=2.5 - 3.5 mg | ||
|InsufflatedROA_Heavy=3.5 - 4+ | |InsufflatedROA_Heavy=3.5 - 4 mg + | ||
|InsufflatedROA_TimelineFile= | |InsufflatedROA_TimelineFile= | ||
|InsufflatedROA_TimelineWidth= | |InsufflatedROA_TimelineWidth= | ||
| Line 74: | Line 74: | ||
|OralROA_Common=[[Oral min common dose::1.5]] - [[Oral max common dose::2.5]] mg | |OralROA_Common=[[Oral min common dose::1.5]] - [[Oral max common dose::2.5]] mg | ||
|OralROA_Strong=[[Oral min strong dose::2.5]] - [[Oral max strong dose::5]] mg | |OralROA_Strong=[[Oral min strong dose::2.5]] - [[Oral max strong dose::5]] mg | ||
|OralROA_Heavy=[[Oral heavy dose::5]]+ | |OralROA_Heavy=[[Oral heavy dose::5]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
Revision as of 17:36, 18 January 2016
| SubstanceBox/DOC | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||
| Common names | DOC | ||||||||||||||||||||||||||||||||||||||||||||||||
| Substitutive name | 2,5-Dimethoxy-4-chloroamphetamine | ||||||||||||||||||||||||||||||||||||||||||||||||
| Systematic name | 1-(4-chloro-2,5-dimethoxy-phenyl)propan-2-amine | ||||||||||||||||||||||||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||
| Psychoactive class | Psychedelic | ||||||||||||||||||||||||||||||||||||||||||||||||
| Chemical class | Phenethylamine | ||||||||||||||||||||||||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||